Germany
Japan
United Kingdom
China
Rabbit polyclonal anti-GAPDH antibody, Loading control
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide conjugated to KLH derived from within residues 220 - 290 of Human GAPDH. |
Antibodies
View as table Download
Rabbit polyclonal anti-GAPDH antibody, Loading control
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide conjugated to KLH derived from within residues 220 - 290 of Human GAPDH. |
Rabbit polyclonal Bi-Phospho-ERK1/2(T202/Y204) Antibody
| Applications | Dot, WB |
| Reactivities | Human (Predicted: Mouse, Rat, Drosophila) |
| Conjugation | Unconjugated |
| Immunogen | This ERK1/2 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding T202/Y204 of human ERK1/2. |
| Modifications | Phospho-specific |
Rabbit Polyclonal Smad2/3 (Thr8) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human Smad2/3 around the phosphorylation site of Threonine 8 |
| Modifications | Phospho-specific |
Anti-GREM1 Rabbit Polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to a region derived from 25-184 amino acids of human gremlin 1 |
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Rabbit Polyclonal VEGFR2 (Tyr1214) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human VEGFR2 around the phosphorylation site of Tyrosine 1214 |
| Modifications | Phospho-specific |
N-cadherin Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide of human N-cadherin |
Rabbit Polyclonal JNK1/2/3 (Thr183+Tyr185) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human JNK1/2/3 around the phosphorylation site of Threonine 183+Tyrosine 185 |
| Modifications | Phospho-specific |
Active filters
Reactivities
- Rat
Antibody Hosts
- Rabbit
Isotypes
- IgG
Clonalities
- Polyclonal
Families
- ES Cell Differentiation/IPS
Citations
- Yes
Filter by
Category
Target Symbol
- GAPDH (3)
- VEGF RECEPTOR 2 (3)
- AKT1 (2)
- BETA CATENIN (2)
- ERK1 (2)
- GLUCOSE TRANSPORTER GLUT1 (2)
- JMJD6 (2)
- JNK1 (2)
- STAT5A (2)
- TGF BETA 1 (2)
- ABCG2 (1)
- BDNF (1)
- BETA ACTIN (1)
- BETA III TUBULIN (1)
- CASEIN KINASE 1 ALPHA (1)
- CASPASE 3 (1)
- CD117 (1)
- CD133 (1)
- CD44 (1)
- CD56 (1)
- CEBP ALPHA (1)
- DLL4 (1)
- EPCAM (1)
- GATA4 (1)
- GFAP (1)
- GREMLIN 1 (1)
- IGF1 (1)
- INTEGRIN ALPHA 4 (1)
- LAMP1 (1)
- LIF (1)
- N CADHERIN (1)
- NEUROD1 (1)
- SMAD3 (1)
- SMOOTHENED (1)
- SOX9 (1)
- TAPA1 (1)
Conjugates
Modifications
Assay Types
Pathways
- Pathways in cancer (20)
- Focal adhesion (14)
- Colorectal cancer (12)
- MAPK signaling pathway (10)
- Chronic myeloid leukemia (9)
- Pancreatic cancer (9)
- Acute myeloid leukemia (8)
- ErbB signaling pathway (8)
- Renal cell carcinoma (8)
- Cytokine-cytokine receptor interaction (7)
- Neurotrophin signaling pathway (7)
- Progesterone-mediated oocyte maturation (7)
- Prostate cancer (7)
- VEGF signaling pathway (7)
- Adherens junction (6)
- Adipocytokine signaling pathway (6)
- Alzheimer's disease (6)
- Endometrial cancer (6)
- Fc epsilon RI signaling pathway (6)
- Insulin signaling pathway (6)
- Toll-like receptor signaling pathway (6)
- Wnt signaling pathway (6)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (5)
- B cell receptor signaling pathway (5)
- Dilated cardiomyopathy (5)
- Glioma (5)
- Hypertrophic cardiomyopathy (HCM) (5)
- Jak-STAT signaling pathway (5)
- Melanogenesis (5)
- Melanoma (5)
- TGF-beta signaling pathway (5)
- Tight junction (5)
- mTOR signaling pathway (5)
- Chemokine signaling pathway (4)
- Endocytosis (4)
- Fc gamma R-mediated phagocytosis (4)
- GnRH signaling pathway (4)
- Leukocyte transendothelial migration (4)
- NOD-like receptor signaling pathway (4)
- Non-small cell lung cancer (4)
- Pathogenic Escherichia coli infection (4)
- Regulation of actin cytoskeleton (4)
- T cell receptor signaling pathway (4)
- Thyroid cancer (4)
- Type II diabetes mellitus (4)
- Apoptosis (3)
- Basal cell carcinoma (3)
- Cell adhesion molecules (CAMs) (3)
- Cell cycle (3)
- Epithelial cell signaling in Helicobacter pylori infection (3)
- Gap junction (3)
- Glycolysis / Gluconeogenesis (3)
- Hematopoietic cell lineage (3)
- Long-term depression (3)
- Metabolic pathways (3)
- Natural killer cell mediated cytotoxicity (3)
- Oocyte meiosis (3)
- Prion diseases (3)
- Axon guidance (2)
- Bladder cancer (2)
- Dorso-ventral axis formation (2)
- ECM-receptor interaction (2)
- Hedgehog signaling pathway (2)
- Huntington's disease (2)
- Long-term potentiation (2)
- RIG-I-like receptor signaling pathway (2)
- Small cell lung cancer (2)
- Vascular smooth muscle contraction (2)
- Viral myocarditis (2)
- p53 signaling pathway (2)
- ABC transporters (1)
- Amyotrophic lateral sclerosis (ALS) (1)
- Lysosome (1)
- Maturity onset diabetes of the young (1)
- Notch signaling pathway (1)
- Parkinson's disease (1)
- Vibrio cholerae infection (1)